Management Team

The BioPharmX management team consists of seasoned global executives, scientists and business professionals combining large company discipline and early stage company creativity with deep biotech expertise focused on drug delivery and execution of complex development programs. The team has the proven ability to streamline new technologies into viable, marketable and successful products.

Anja Krammer, President & Co-founder

A Silicon Valley veteran, Ms. Krammer has deep experience guiding healthcare and other enterprises to identify and fulfill unmet patient and consumer needs. She has led commercial organizations at diverse companies, such as aesthetic market leader Reliant Technologies, biomedical engineer Medtronic, imaging manufacturer Tektronix and telecommunications giant AT&T. As the founder of a boutique management consulting firm, she has also counseled companies such as American Express, GSK, Medicis Pharmaceuticals and Weight Watchers NA. Krammer graduated from the University of South Carolina and completed post-graduate studies at Webster University and the University of Paris – Sorbonne.

"Our mission at BioPharmX is to fulfill the unmet needs of millions of people whose dermatological conditions have been overlooked by others."

Greg Kitchener, Chief Financial Officer

Mr. Kitchener has over 20 years of broad financial leadership experience in financial planning and analysis, treasury, accounting and investor relations. He has a diverse industry background in technology companies such as Cisco Systems and Synopsys, and with the molecular diagnostics company, Cepheid, where he most recently served as vice president of finance. Kitchener holds a Master of Business Administration from Cornell University and a Bachelor of Science in mathematics from University of California, Santa Cruz.

"Helping the company make prudent financial decisions that deliver sustainable growth, predictable results, and return high shareholder value is the best sense of achievement."

Kin F. Chan, Ph.D., Executive Vice President of Research and Technology

Dr. Chan is a serial biomedical entrepreneur who has developed novel, effective therapies for diverse medical conditions. His research and product development experience spans semiconductors, lasers/photonics, medical devices and biomedical sciences. He has therapeutic experience in dermatology, cardiology, urology and ophthalmology. Prior to BioPharmX, Chan was Vice President of Engineering at Dermira, where he helped develop photodynamic therapies, and directed advanced research at Solta Medical, where he helped create fractional photothermolysis technology. He is a named inventor on more than 25 patents and pending patent applications. Chan holds a Ph.D. in electrical and computer engineering from the University of Texas at Austin, where he also achieved his bachelors and masters degrees.

"BioPharmX is driven not only by a desire to explore what is possible through scientific breakthroughs, but also by what science can do to satisfy the needs of patients."

AnnaMarie Daniels, Executive Vice President of Regulatory and Clinical Affairs

Ms. Daniels is a microbiologist and biochemist by training and holds multiple patents. She has authored or contributed to dozens of peer reviewed articles and abstracts on subjects ranging from in vitro assays to breast cancer prevention. For the last 35 years she has held technical and executive level positions in start-up and development stage pharmaceutical and medical device companies working in the areas of implantable biomaterials, oncology, women’s health, pain, urology and interventional neuroradiology. She has been responsible for all aspects of company operations and has specific expertise in design and implementation of clinical and regulatory strategy for new product development. Prior to joining BioPharmX, she led the botulinum neurotoxin program at Johnson & Johnson, the clinical research program for Boston Scientific Neuromodulation and served as an independent consultant for a number of pharmaceutical and medical device companies.

"Being a part of a team committed to bringing new technologies to market that change people’s lives is the most exciting way to start each day."

Marie-Louise Bots, Senior Vice President of Corporate Development

A seasoned executive with decades of experience in creating license, distribution and other agreements, Ms. Bots guides BioPharmX’s licensing and strategic partnerships. During her three-decade career, she has used licensing, partnerships and strategic acquisitions to boost the sales and profitability at several multinationals. As head of the global skincare business of Royal Philips Electronics NV, she oversaw partnership development and acquisitions, managed joint ventures with companies around the world and launched R&D programs resulting in products sold internationally. Earlier, she managed Philips’ Oral Health Care operations in EMEA leading to growth and profitability. Ms. Bots has also served in executive roles where she built, inspired and managed multi-cultural teams at Aon Risk Solutions, Reed/Elsevier, Beam Suntory, Altadis USA and Royal Agio Cigars. She has a degree in Economics from Fontys University of Applied Sciences in Eindhoven, Netherlands, and she has studied at Erasmus University in Rotterdam and Babson College in Boston.

"The right partnership and licensing agreements can help BioPharmX achieve its true potential by enabling the company to more effectively focus its resources on fulfilling the unmet medical needs of patients worldwide."

G. Scott Herron, M.D., Ph.D., Medical Director

Dr. Herron is a physician scientist with nearly three decades of dermatology experience and maintains an active clinical practice in Palo Alto, California. As faculty at Stanford University School of Medicine he conducted biomedical research, consulted with the biopharmaceutical industry, authored or co-authored more than 30 peer-reviewed papers, and secured several patents in the biomedical field. In addition he held the position of medical director for Reliant Technologies. Dr. Herron has been honored for his work in the field and is repeatedly recognized as a thought-leading physician. He graduated from Lewis and Clark College with degrees in chemistry and biology, completed his doctoral work at Oregon State University in biochemistry and biophysics and obtained his medical doctor degree from University of Southern California Medical School.

"Dermatologists must address both physical and emotional issues because the conditions they treat often shape patients’ self-esteem. Our mission is to provide them more innovative therapeutic options to address some of the most common skin conditions."

R. Kehl Sink, Ph.D., Senior Vice President of Intellectual Property and Legal

Dr. Sink has a passion for capturing value from the scientific energy of small technology companies. Prior to his role at BioPharmX, Dr. Sink led the Intellectual Property Department at Reliant Technologies, a medical device company in Mountain View, CA, and held a clinical leadership role at Acclarent, a Johnson & Johnson company. He is registered to practice before the U. S. Patent and Trademark Office and is a named inventor on nine granted patents. Dr. Sink graduated from Swarthmore College where he received Bachelor of Science and Bachelor of Arts degrees and obtained both his Master of Science and Ph.D. from University of California, Santa Barbara.

"BioPharmX protects its intellectual property to create commercially viable opportunities that bring innovative products to patients."

José Zayas, Ph.D., Senior Vice President of Operations

Dr. Zayas has over 30 years of experience in operations, quality management, and research and development in antimicrobial molecules and products with an emphasis in dermatology and respiratory applications. Prior to joining BioPharmX, he headed the analytical section for GlaxoSmithKline and formulated generic injectables at Lederle Parenterals and was most recently VP of Quality Assurance and Regulatory Affairs at Ionetix Corporation. Dr. Zayas has hosted and/or participated in over 40 FDA pre-approval inspections. As founder of Zaycor Industries, a contract testing laboratory, research and development, and consulting firm, Dr. Zayas brings expertise in technology transfer, manufacturing process, stability studies and all CMC-related items to BioPharmX. Dr. Zayas has authored over a dozen publications across multiple disciplines and is the author of a patent and several pending patent applications. He holds a Ph.D. in organic chemistry from Ohio State University and completed his postdoctoral in organic chemistry from Princeton University.

"Consistently aligning internal processes with the patient in mind is at the heart of any successful operational execution."